Literature DB >> 25260822

Development of an in vitro ocular test system for the prediction of all three GHS categories.

M Bartok1, D Gabel2, M Zorn-Kruppa3, M Engelke2.   

Abstract

In the present study we considered a new approach that allows the individual quantification of damages induced in the epithelium and stroma of an in vitro hemi-cornea model after chemical treatment. We aimed at a stand-alone test system for classification according to the classification of the globally harmonized system of classification and labelling of chemicals (GHS). We have modified a previously developed 3D hemi-cornea model by the insertion of a collagen membrane between epithelium and stroma. This membrane allows the separation and independent assessment of these compartments after topical exposure to potential eye irritants. The cell viability quantified by MTT assay was used as the toxicological endpoint. The prediction model based on the results obtained from 30 test chemicals uses a single exposure period and the combination of cut-off values in tissue viability from both epithelium and stroma. The in vitro-in vivo concordance of the test system is 77%. All of the GHS category 1, 80% of the GHS category 2 and 50% of the GHS not categorized chemicals are predicted correctly. In conclusion, the test system predicts and discriminates GHS category 1 and GHS category 2 chemicals, but is over-predictive for GHS not categorized materials.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Eye irritation; GHS classification; Human hemi-cornea model; Prediction model; Predictive capacity

Mesh:

Year:  2014        PMID: 25260822     DOI: 10.1016/j.tiv.2014.09.005

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  1 in total

Review 1.  Chitosan-Based In Situ Gels for Ocular Delivery of Therapeutics: A State-of-the-Art Review.

Authors:  Teodora Irimia; Cristina-Elena Dinu-Pîrvu; Mihaela Violeta Ghica; Dumitru Lupuleasa; Daniela-Lucia Muntean; Denisa Ioana Udeanu; Lăcrămioara Popa
Journal:  Mar Drugs       Date:  2018-10-09       Impact factor: 5.118

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.